Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetic Algorithm of Response to Warfarin During Initial Anticoagulation in Chinese Elderly Patients

NCT02211326 is registered in ClinicalTrials.gov with The Third Xiangya Hospital of Central South University as lead sponsor.

NCT NCT02211326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02211326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetic Algorithm of Response to Warfarin During Initial Anticoagulation in Chinese Elderly Patients
Lead sponsor
The Third Xiangya Hospital of Central South University
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2014
Completion date
May 1, 2017
Enrollment
660 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, deep venous thrombosis